OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Vascular and metabolic effects of SGLT2i and GLP-1 in heart failure patients
Michele Correale, Olga Lamacchia, Michele Ciccarelli, et al.
Heart Failure Reviews (2021) Vol. 28, Iss. 3, pp. 733-744
Closed Access | Times Cited: 25
Michele Correale, Olga Lamacchia, Michele Ciccarelli, et al.
Heart Failure Reviews (2021) Vol. 28, Iss. 3, pp. 733-744
Closed Access | Times Cited: 25
Showing 25 citing articles:
Gliflozins in the Management of Cardiovascular Disease
Eugene Braunwald
New England Journal of Medicine (2022) Vol. 386, Iss. 21, pp. 2024-2034
Closed Access | Times Cited: 174
Eugene Braunwald
New England Journal of Medicine (2022) Vol. 386, Iss. 21, pp. 2024-2034
Closed Access | Times Cited: 174
Role of Epicardial Adipose Tissue in Cardiovascular Diseases: A Review
Michał Konwerski, Aleksandra Gąsecka, Grzegorz Opolski, et al.
Biology (2022) Vol. 11, Iss. 3, pp. 355-355
Open Access | Times Cited: 72
Michał Konwerski, Aleksandra Gąsecka, Grzegorz Opolski, et al.
Biology (2022) Vol. 11, Iss. 3, pp. 355-355
Open Access | Times Cited: 72
Advancing lifelong precision medicine for cardiovascular diseases through gut microbiota modulation
Bozhong Shi, Haoyu Li, Xiaomin He
Gut Microbes (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 11
Bozhong Shi, Haoyu Li, Xiaomin He
Gut Microbes (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 11
Diabetic cardiomyopathy: a brief summary on lipid toxicity
Jiahan Ke, Jianan Pan, Hao Lin, et al.
ESC Heart Failure (2022) Vol. 10, Iss. 2, pp. 776-790
Open Access | Times Cited: 28
Jiahan Ke, Jianan Pan, Hao Lin, et al.
ESC Heart Failure (2022) Vol. 10, Iss. 2, pp. 776-790
Open Access | Times Cited: 28
Semaglutide inhibits ischemia/reperfusion-induced cardiomyocyte apoptosis through activating PKG/PKCε/ERK1/2 pathway
Qiuxia Zhu, Yong Luo, Yuetao Wen, et al.
Biochemical and Biophysical Research Communications (2023) Vol. 647, pp. 1-8
Open Access | Times Cited: 15
Qiuxia Zhu, Yong Luo, Yuetao Wen, et al.
Biochemical and Biophysical Research Communications (2023) Vol. 647, pp. 1-8
Open Access | Times Cited: 15
Gliflozins: From Antidiabetic Drugs to Cornerstone in Heart Failure Therapy—A Boost to Their Utilization and Multidisciplinary Approach in the Management of Heart Failure
Lorenzo Pistelli, Francesca Parisi, Michele Correale, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 1, pp. 379-379
Open Access | Times Cited: 12
Lorenzo Pistelli, Francesca Parisi, Michele Correale, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 1, pp. 379-379
Open Access | Times Cited: 12
Early Use of Liraglutide for the Treatment of Acute COVID-19 Infection: An Open-Label Single-Center Phase II Safety Study with Biomarker Profiling
Eloara V.M. Ferreira, Rudolf K.F. Oliveira, Reinaldo Salomão, et al.
Infectious Disease Reports (2025) Vol. 17, Iss. 1, pp. 5-5
Open Access
Eloara V.M. Ferreira, Rudolf K.F. Oliveira, Reinaldo Salomão, et al.
Infectious Disease Reports (2025) Vol. 17, Iss. 1, pp. 5-5
Open Access
Therapeutic potential of ketone bodies on exercise intolerance in heart failure: looking beyond the heart
Shubham Soni, Rachel J. Skow, Stephen J. Foulkes, et al.
Cardiovascular Research (2025)
Closed Access
Shubham Soni, Rachel J. Skow, Stephen J. Foulkes, et al.
Cardiovascular Research (2025)
Closed Access
Emerging Roles of Sodium Glucose Cotransporter 2 (SGLT-2) Inhibitors in Diabetic Cardiovascular Diseases: Focusing on Immunity, Inflammation and Metabolism
Lingxiang Xie, Yang Xiao, Shi Tai, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 17
Lingxiang Xie, Yang Xiao, Shi Tai, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 17
High-Sensitivity Cardiac Troponin T Elevation and Paroxysmal Supraventricular Tachycardia. Is it Always Acute Coronary Syndrome?
Serena Miccichè, Giuseppe Pelaggi, Maria Claudia Lo Nigro, et al.
Cor et Vasa (2025) Vol. 67, Iss. 1, pp. 77-81
Open Access
Serena Miccichè, Giuseppe Pelaggi, Maria Claudia Lo Nigro, et al.
Cor et Vasa (2025) Vol. 67, Iss. 1, pp. 77-81
Open Access
Epicardial adipose tissue as target of the incretin-based therapies in cardio-metabolic pathologies: a narrative review
Alexandra Pop, Maria D. Dănilă, Silvia Giuchici, et al.
Canadian Journal of Physiology and Pharmacology (2025)
Closed Access
Alexandra Pop, Maria D. Dănilă, Silvia Giuchici, et al.
Canadian Journal of Physiology and Pharmacology (2025)
Closed Access
Effect of empagliflozin on myocardial structure and function in patients with type 2 diabetes at high cardiovascular risk: the SIMPLE randomized clinical trial
Mads Ersbøll, Mikkel Jürgens, Philip Hasbak, et al.
The International Journal of Cardiovascular Imaging (2021) Vol. 38, Iss. 3, pp. 579-587
Closed Access | Times Cited: 18
Mads Ersbøll, Mikkel Jürgens, Philip Hasbak, et al.
The International Journal of Cardiovascular Imaging (2021) Vol. 38, Iss. 3, pp. 579-587
Closed Access | Times Cited: 18
Association between Dapagliflozin, Cardiac Biomarkers and Cardiac Remodeling in Patients with Diabetes Mellitus and Heart Failure
Αndrew Xanthopoulos, Νικόλαος Κατσιάδας, Spyridon Skoularigkis, et al.
Life (2023) Vol. 13, Iss. 8, pp. 1778-1778
Open Access | Times Cited: 5
Αndrew Xanthopoulos, Νικόλαος Κατσιάδας, Spyridon Skoularigkis, et al.
Life (2023) Vol. 13, Iss. 8, pp. 1778-1778
Open Access | Times Cited: 5
Switch to gliflozins and biventricular function improvement in patients with chronic heart failure and diabetes mellitus
Michele Correale, Pietro Mazzeo, Martino Fortunato, et al.
Clinical Physiology and Functional Imaging (2023) Vol. 44, Iss. 1, pp. 112-117
Open Access | Times Cited: 4
Michele Correale, Pietro Mazzeo, Martino Fortunato, et al.
Clinical Physiology and Functional Imaging (2023) Vol. 44, Iss. 1, pp. 112-117
Open Access | Times Cited: 4
Distinct Profiles and New Pharmacological Targets for Heart Failure with Preserved Ejection Fraction
Alberto Palazzuoli, Paolo Severino, Andrea D’Amato, et al.
Reviews in Cardiovascular Medicine (2024) Vol. 25, Iss. 7
Open Access | Times Cited: 1
Alberto Palazzuoli, Paolo Severino, Andrea D’Amato, et al.
Reviews in Cardiovascular Medicine (2024) Vol. 25, Iss. 7
Open Access | Times Cited: 1
The potential of glucagon-like peptide-1 receptor agonists in heart failure
Frederik Flindt Kreiner, G. Kees Hovingh, Bernt Johan von Scholten
Frontiers in Physiology (2022) Vol. 13
Open Access | Times Cited: 7
Frederik Flindt Kreiner, G. Kees Hovingh, Bernt Johan von Scholten
Frontiers in Physiology (2022) Vol. 13
Open Access | Times Cited: 7
Gut Molecules in Cardiometabolic Diseases: The Mechanisms behind the Story
Andreea-Ioana Inceu, Maria Adriana Neag, Anca-Elena Crăciun, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3385-3385
Open Access | Times Cited: 3
Andreea-Ioana Inceu, Maria Adriana Neag, Anca-Elena Crăciun, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3385-3385
Open Access | Times Cited: 3
Rationale and design of the Biventricular Evaluation of Gliflozins effects In chroNic Heart Failure: BEGIN‐HF study
Michele Correale, Elena‐Laura Antohi, Riccardo M. Inciardi, et al.
ESC Heart Failure (2023) Vol. 10, Iss. 3, pp. 2066-2073
Open Access | Times Cited: 3
Michele Correale, Elena‐Laura Antohi, Riccardo M. Inciardi, et al.
ESC Heart Failure (2023) Vol. 10, Iss. 3, pp. 2066-2073
Open Access | Times Cited: 3
Endothelial Function in Patients with Multiple Sclerosis: The Role of GLP-1 Agonists, Lipoprotein Subfractions, and Redox Balance
Miroslava Hardoňová, Pavel Šiarnik, Monika Siváková, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 13, pp. 11162-11162
Open Access | Times Cited: 3
Miroslava Hardoňová, Pavel Šiarnik, Monika Siváková, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 13, pp. 11162-11162
Open Access | Times Cited: 3
Advances in Metabolic Remodeling and Intervention Strategies in Heart Failure
Simin Meng, Yi Yu, Shuo Yu, et al.
Journal of Cardiovascular Translational Research (2023) Vol. 17, Iss. 1, pp. 36-55
Closed Access | Times Cited: 3
Simin Meng, Yi Yu, Shuo Yu, et al.
Journal of Cardiovascular Translational Research (2023) Vol. 17, Iss. 1, pp. 36-55
Closed Access | Times Cited: 3
SGLT2 Inhibitors: Statins or ACE-Inhibitors of the 21st Century?
Michele Correale, Lucia Tricarico, Massimo Iacoviello, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 7, pp. 2695-2695
Open Access | Times Cited: 2
Michele Correale, Lucia Tricarico, Massimo Iacoviello, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 7, pp. 2695-2695
Open Access | Times Cited: 2
An update on diabetes spectrum in heart failure: current evidence and potential therapeutic applications
Alberto Palazzuoli, Gianluigi Savarese
Heart Failure Reviews (2022) Vol. 28, Iss. 3, pp. 573-575
Closed Access | Times Cited: 1
Alberto Palazzuoli, Gianluigi Savarese
Heart Failure Reviews (2022) Vol. 28, Iss. 3, pp. 573-575
Closed Access | Times Cited: 1
Promising directions in the treatment of chronic heart failure: improving old or developing new ones?
V. V. Kalyuzhin, А. T. Teplyakov, И. Д. Беспалова, et al.
Bulletin of Siberian Medicine (2022) Vol. 21, Iss. 3, pp. 181-197
Open Access | Times Cited: 1
V. V. Kalyuzhin, А. T. Teplyakov, И. Д. Беспалова, et al.
Bulletin of Siberian Medicine (2022) Vol. 21, Iss. 3, pp. 181-197
Open Access | Times Cited: 1
Vascular Damage and Glycometabolic Control in Older Patients with Type 2 Diabetes
David Karásek, Jaromíra Spurná, Dominika Mačáková, et al.
Metabolites (2023) Vol. 13, Iss. 3, pp. 382-382
Open Access
David Karásek, Jaromíra Spurná, Dominika Mačáková, et al.
Metabolites (2023) Vol. 13, Iss. 3, pp. 382-382
Open Access
New principles for the treatment of chronic heart failure: the phenomenon of sodium-glucose cotransporter type 2 inhibitors
S. G. Кanorskiy
Meditsinskiy sovet = Medical Council (2022), Iss. 17, pp. 44-51
Open Access
S. G. Кanorskiy
Meditsinskiy sovet = Medical Council (2022), Iss. 17, pp. 44-51
Open Access
